Compounds > angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-
Page last updated: 2024-09-03

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and cardiovascular agents

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with cardiovascular agents in 1 studies

Compound Research Comparison

Studies
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)		Trials
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)		Recent Studies (post-2010)
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)		Studies
(cardiovascular agents)		Trials
(cardiovascular agents)		Recent Studies (post-2010) (cardiovascular agents)
31156417,6451,4806,891

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaitman, BR; Friedman, JB; Ivleva, AY; Lawrence, JH; Lenis, JH; Pangerl, AM; Reisin, LH; Stieber, DM; Toth, C; Ujda, M1

Trials

1 trial(s) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and cardiovascular agents

ArticleYear
Antianginal efficacy of omapatrilat in patients with chronic angina pectoris.
    The American journal of cardiology, 2005, Jun-01, Volume: 95, Issue:11

    Topics: Angina Pectoris; Angiotensin II; Angiotensin III; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Chronic Disease; Double-Blind Method; Exercise Tolerance; Female; Humans; Male; Middle Aged; Neprilysin; Pyridines; Thiazepines

2005